Vabysmo TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: faricimab
Brand name
(ARTG)
: VABYSMO faricimab 120 mg/mL solution for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Vabysmo is indicated for the treatment of:,-Neovascular (wet) age-related macular degeneration (nAMD),,-Diabetic macular oedema (DMO),,-Macular oedema secondary to retinal vein occlusion (RVO).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravitreal-Within The Vitreous Cavity Of The Eye
- A clear and slightly opalescent, colourless to brownish-yellow liquid, contained in a Type I colourless glass vial.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial (commercial pack) pack
- 1 vial (Physician's starter pack) pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient faricimab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
